|8.71||-0.24 / -2.68%|
Data as of 4:00pm ET
|8.71||+0.0017 / +0.02%|
The 7 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 18.00 and a low estimate of 12.00. The median estimate represents a +72.22% increase from the last price of 8.71.
The current consensus among 7 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.